XML 43 R21.htm IDEA: XBRL DOCUMENT
v3.26.1

Share-Based Payment in a Consolidated Subsidiary | 12 Months Ended
--- | ---
Dec. 31, 2025
Share-Based Payment in a Consolidated Subsidiary [Abstract] |
SHARE-BASED PAYMENT IN A CONSOLIDATED SUBSIDIARY | NOTE 15 – SHARE-BASED PAYMENT IN A CONSOLIDATED SUBSIDIARY On January 1, 2023, the Company granted 957,345 options to employees and officers with an exercise price ranging between $1.265 and $2.79 per option. The options are exercisable to shares in a 1:1 ratio. The options will vest over a period of 3 years. On January 9, 2023, the Company granted 24,662 options to employees with an exercise price of $1.37 per option. The options are exercisable to shares in a 1:1 ratio. The options will vest over a period of three years. The fair value of the aforesaid options was estimated on their award date at $5,381, with the assistance of an independent external appraiser, using the Black-Scholes pricing model. Set forth below are the parameters used in determining the fair value of the options:
The Company share price ($) (*) |  | 6.8 |  |
Exercise price (in $) |  | 2.79 - 1.265 |  | See above.
Expected volatility in the Company’s share price |  | 49.4% - 39.9% |  |
Expected life of the warrants (in years) |  | 8 – 5 |  |
Risk-free interest |  | 3.86% - 4.29% |  |
Expected dividend yield |  | - |  |
(*) | The Company’s share price is determined based on the Company’s value as appraised by the appraiser as of the award date, while using the discounted cash flow method, and at a discount rate of 18%.
On January 31, 2024, the Company granted 100,520 options to the Company’s directors at an exercise price of $4.00 per option, for a vesting period of 3 years. The options expire in 5 years from the granted date. The fair value of the aforesaid options was estimated on their award date at $77, using the Black-Scholes pricing model. Set forth below are the parameters used in determining the fair value of the options:
The Company share price ($) (*) |  | 3.05
Exercise price (in $) |  | 4
Expected volatility in the Company’s share price |  | 40.84%
Expected life of the warrants (in years) |  | 4 – 3
Risk-free interest |  | 4%
Expected dividend yield |  | -
(*) | The Company’s share price is determined based on the granted date.
On February 27, 2025, the Company granted 106,812 options to employees with an exercise price of $3.97 per option. The options are exercisable to shares in a 1:1 ratio. The options will vest over a period of 3 years. The fair value of the aforesaid options was estimated on their award date at $168,782, using the Black-Scholes pricing model. Set forth below are the parameters used in determining the fair value of the options:
Company share price ($) |  | 3.75
Exercise price (in $) |  | 1.8
Expected volatility in the Company’s share price |  | 40.48%
Expected life of the warrants (in years) |  | 5
Risk-free interest |  | 4%
Set forth below are the movements in options awarded to Company employees and officers in the reporting years:
|  | For the year ended December 31, |
|  | 2025 |  |  | 2024 |
|  | No. of options |  |  | Weighted Average Exercise Price |  |  | No. of options |  |  | Weighted Average Exercise Price |
Outstanding at beginning of year |  |  | 1,183,939 |  |  |  | 2.14 |  |  |  | 1,096,652 |  |  |  | 1.97 |
Granted during the year |  |  | 806,812 |  |  |  | 1.17 |  |  |  | 100,520 |  |  |  | 4.00 |
Exercised during the year |  |  | (3,794 | ) |  |  | 1.37 |  |  |  | - |  |  |  | - |
Expired and/or forfeited during the year |  |  | (21,579 | ) |  |  | 13.29 |  |  |  | (13,233 | ) |  |  | 1.59 |
Outstanding at ending of year |  |  | 1,965,378 |  |  |  | 1.62 |  |  |  | 1,183,939 |  |  |  | 2.14 |
Exercisable at the end of the year |  |  | 944,735 |  |  |  | 1.79 |  |  |  | 714,778 |  |  |  | 1.99 |
On December 30, 2025, the Company granted 700,000 options to the Company’s directors at an exercise price of $1.07 per option, for a vesting period of 3 years. The options expire in 10 years from the granted date.

X
- Definition The entire disclosure for share-based payment arrangements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 44 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration